Showing results (41-50 of 54) with videos related to
Sort By:
Pageof 6
Allergy and Asthma Proceedings|July 11, 2007
Efficacy of montelukast for treating perennial allergic rhinitisGeorge Philip, Debora Williams-Herman, Piyush Patel, et al.Inflammatory Bowel Diseases|February 12, 2021
Colectomy Incidence Rates in Five-Year Data From the Observational Postmarketing Ulcerative Colitis Study of Originator InfliximabJulián Panés, James O Lindsay, Niels Teich, et al.American Journal of Rhinology|January 13, 2006
Montelukast effectively treats the nighttime impact of seasonal allergic rhinitisEli O Meltzer, George Philip, Steven F Weinstein, et al.Allergy and Asthma Proceedings|August 18, 2006
Validation of the nighttime symptoms score as a clinically relevant measure of allergic rhinitisNancy C Santanello, Carla DeMuro-Mercon, Shailen R Shah, et al.The Journal of Allergy and Clinical Immunology|February 6, 2013
Effect of montelukast for treatment of asthma in cigarette smokersDavid Price, Todor A Popov, Leif Bjermer, et al.Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 9, 2006
Onset and duration of protection against exercise-induced bronchoconstriction by a single oral dose of montelukastDavid S Pearlman, Janet van Adelsberg, George Philip, et al.Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 31, 2004
Montelukast for treating fall allergic rhinitis: effect of pollen exposure in 3 studiesPaul Chervinsky, George Philip, Marie-Pierre Malice, et al.Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|January 13, 2006
Randomized, double-blind, placebo-controlled study of montelukast for treating perennial allergic rhinitisPiyush Patel, George Philip, William Yang, et al.Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 1, 2011
Intermittent or daily montelukast versus placebo for episodic asthma in childrenErkka Valovirta, Maria L Boza, Colin F Robertson, et al.Journal of Crohn'S & Colitis|February 28, 2019
Five-year Safety Data From OPUS, a European Observational Safety Registry for Adults With Ulcerative Colitis Treated With Originator Infliximab [Remicade®] or Conventional TherapyJulián Panés, James O Lindsay, Niels Teich, et al.Pageof 6